Tumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65 Methylation

Journal of Biological Chemistry

Volumn 289, Issue 22, 2014, Pages 15328-15339

  Harris, Daniel P ^a,b   Bandyopadhyay, Smarajit ^a   Maxwell, Tyler J ^a   Willard, Belinda ^a   DiCorleto, Paul E ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; CHEMICAL ACTIVATION; ENDOTHELIAL CELLS; METHYLATION;

ARGININE RESIDUE; CHEMOKINES; NUCLEAR FACTORS; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN-ARGININE METHYLTRANSFERASE; TRANSCRIPTIONAL ACTIVATIONS; TUMOR NECROSIS FACTORS;

ARGININE;

GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; RNA INTERFERENCE; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

ENDOTHELIAL CELL; GENE EXPRESSION; NF-KAPPA B (NF-KB); POST-TRANSLATIONAL MODIFICATION (PTM); PROTEIN METHYLATION; TUMOR NECROSIS FACTOR (TNF);

ARGININE; CHEMOKINE CXCL10; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; METHYLATION; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-ARGININE N-METHYLTRANSFERASES; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901719109     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.547349     Document Type: Article

References (41)

1. Medzhitov, R., and Horng, T. (2009) Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9, 692-703
2. Bandyopadhyay, S., Harris, D. P., Adams, G. N., Lause, G. E., McHugh, A., Tillmaand, E. G., Money, A., Willard, B., Fox, P. L., and Dicorleto, P. E. (2012) HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules. Mol. Cell. Biol. 32, 1202-1213
3. Boisvert, F. M., and Richard, S. (2004) Arginine methylation regulates the cytokine response. Mol. Cell 15, 492-494
4. Hassa, P. O., Covic, M., Bedford, M. T., and Hottiger, M. O. (2008) Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J. Mol. Biol. 377, 668-678
5. Richard, S., Morel, M., and Cléroux, P. (2005) Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). Biochem. J. 388, 379-386
6. Yang, Y., and Bedford, M. T. (2013) Protein arginine methyltransferases and cancer. Nat. Rev. Cancer 13, 37-50
7. Krause, C. D., Yang, Z. H., Kim, Y. S., Lee, J. H., Cook, J. R., and Pestka, S. (2007) Protein arginine methyltransferases: Evolution and assessment of their pharmacological and therapeutic potential. Pharmacol. Ther. 113, 50-87
8. Arkov, A. L., Wang, J. Y., Ramos, A., and Lehmann, R. (2006) The role of Tudor domains in germline development and polar granule architecture. Development 133, 4053-4062
9. Boisvert, F. M., Chénard, C. A., and Richard, S. (2005) Protein interfaces in signaling regulated by arginine methylation. Sci. STKE 2005, re2
10. Groom, J. R., and Luster, A. D. (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207-215
11. Zernecke, A., Shagdarsuren, E., and Weber, C. (2008) Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28, 1897-1908
12. Luster, A. D., Unkeless, J. C., and Ravetch, J. V. (1985) γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315, 672-676
13. Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., and Luster, A. D. (2000) Peroxisome proliferatoractivated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164, 6503-6508
14. Wang, X., Yue, T. L., Ohlstein, E. H., Sung, C. P., and Feuerstein, G. Z. (1996) Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J. Biol. Chem. 271, 24286-24293
15. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., and Tosato, G. (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162
16. Huang, B., Yang, X. D., Lamb, A., and Chen, L. F. (2010) Posttranslational modifications of NF-κB: another layer of regulation for NF-κB signaling pathway. Cell. Signal. 22, 1282-1290
17. Leung, T. H., Hoffmann, A., and Baltimore, D. (2004) One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers. Cell 118, 453-464
18. Baltimore, D. (2011) NF-κB is 25. Nat. Immunol. 12, 683-685
19. Scarpati, E. M., and DiCorleto, P. E. (1996) Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J. Biol. Chem. 271, 3025-3032
20. Bandyopadhyay, S., Ashraf, M. Z., Daher, P., Howe, P. H., and DiCorleto, P. E. (2007) HOXA9 participates in the transcriptional activation of Eselectin in endothelial cells. Mol. Cell. Biol. 27, 4207-4216
21. Majumder, S., Zhou, L. Z., Chaturvedi, P., Babcock, G., Aras, S., and Ransohoff, R. M. (1998) p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-κ. J. Immunol. 161, 4736-4744
22. Ballard, D. W., Dixon, E. P., Peffer, N. J., Bogerd, H., Doerre, S., Stein, B., and Greene, W. C. (1992) The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. U.S.A. 89, 1875-1879
23. Hamilton, T. A., Novotny, M., Datta, S., Mandal, P., Hartupee, J., Tebo, J., and Li, X. (2007) Chemokine and chemoattractant receptor expression: post-transcriptional regulation. J. Leukoc. Biol. 82, 213-219
24. Ohmori, Y., and Hamilton, T. A. (1993) Cooperative interaction between interferon (IFN) stimulus response element and kappa; B sequence motifs controls IFNγ- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268, 6677-6688
25. Fabbrizio, E., El Messaoudi, S., Polanowska, J., Paul, C., Cook, J. R., Lee, J. H., Negre, V., Rousset, M., Pestka, S., Le Cam, A., and Sardet, C. (2002) Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep. 3, 641-645
26. Jansson, M., Durant, S. T., Cho, E. C., Sheahan, S., Edelmann, M., Kessler, B., and La Thangue, N. B. (2008) Arginine methylation regulates the p53 response. Nat. Cell Biol. 10, 1431-1439
27. Wei, H., Wang, B., Miyagi, M., She, Y., Gopalan, B., Huang, D. B., Ghosh, G., Stark, G. R., and Lu, T. (2013) PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. Proc. Natl. Acad. Sci. U.S.A. 110, 13516-13521
28. Chen, F. E., Huang, D. B., Chen, Y. Q., and Ghosh, G. (1998) Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391, 410-413
29. Ruland, J. (2011) Return to homeostasis: downregulation of NF-κB responses. Nat. Immunol. 12, 709-714
30. Oeckinghaus, A., Hayden, M. S., and Ghosh, S. (2011) Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695-708
31. Smale, S. T. (2011) Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 12, 689-694
32. Tweedie-Cullen, R. Y., Brunner, A. M., Grossmann, J., Mohanna, S., Sichau, D., Nanni, P., Panse, C., and Mansuy, I. M. (2012) Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One 7, e36980
33. Feng, Y., Wang, J., Asher, S., Hoang, L., Guardiani, C., Ivanov, I., and Zheng, Y. G. (2011) Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism. J. Biol. Chem. 286, 20323-20334
34. Molina-Serrano, D., Schiza, V., and Kirmizis, A. (2013) Cross-talk among epigenetic modifications: lessons from histone arginine methylation. Biochem. Soc. Trans. 41, 751-759
35. Guo, Z., Zheng, L., Xu, H., Dai, H., Zhou, M., Pascua, M. R., Chen, Q. M., and Shen, B. (2010) Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding. Nat. Chem. Biol. 6, 766-773
36. Hung, C. M., and Li, C. (2004) Identification and phylogenetic analyses of the protein arginine methyltransferase gene family in fish and ascidians. Gene 340, 179-187
37. Fernandes, J. L., Mamoni, R. L., Orford, J. L., Garcia, C., Selwyn, A. P., Coelho, O. R., and Blotta, M. H. (2004) Increased Th1 activity in patients with coronary artery disease. Cytokine 26, 131-137
38. Heller, E. A., Liu, E., Tager, A. M., Yuan, Q., Lin, A. Y., Ahluwalia, N., Jones, K., Koehn, S. L., Lok, V. M., Aikawa, E., Moore, K. J., Luster, A. D., and Gerszten, R. E. (2006) Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatoryTcells. Circulation 113, 2301-2312
39. Kawamura, A., Miura, S., Fujino, M., Nishikawa, H., Matsuo, Y., Tanigawa, H., Tomita, S., Tsuchiya, Y., Matsuo, K., and Saku, K. (2003) CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J. 67, 851-854
40. Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., and Luster, A. D. (1999) Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 104, 1041-1050
41. King, V. L., Lin, A. Y., Kristo, F., Anderson, T. J., Ahluwalia, N., Hardy, G. J., Owens, A. P., 3rd, Howatt, D. A., Shen, D., Tager, A. M., Luster, A. D., Daugherty, A., and Gerszten, R. E. (2009) Interferon-γ and the interferoninducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 119, 426-435